Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
240 participants
INTERVENTIONAL
2021-11-04
2024-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Multimodal analgesia for the management of postoperative pain following THA is now standard of care2,3. It involves a combination of local anesthetic infiltration (LAI), peripheral nerve blocks (PNBs), analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen and/or other medications, including gabapentinoids and opioids. Using multiple analgesic modalities allows for an easier and faster recovery for THA patients and ultimately allows for reduction in postoperative narcotic use and it's associated negative side effects. Total hip arthroplasty can be performed under either general anesthesia, epidural anesthesia or most commonly under spinal anesthesia, with or without epidural morphine. The adjunctive use of LAI, pericapsular nerve group (PENG) block or suprainguinal fascia iliaca compartment block (FICB) for postoperative pain management is becoming more widespread, although evidence on their efficacy has been inconsistent4-8. As such, comparative evaluation of these adjuctive analgesic modalities is imperative to optimize postoperative pain management following THA.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Total Hip Arthroplasty
NCT03069183
The Influence of Local Infiltration Analgesia by Catheter in Postoperative Control Pain After Total Hip Replacement
NCT02630160
Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty
NCT02658149
Perioperative Analgesia for Total Hip Arthroplasty
NCT04670497
Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular
NCT02242201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this randomized trial, the investigators aim to evaluate postoperative pain and side effects related to pain control in patients who receive FICB versus LAI versus PENG block following THA. The investigators aim to compare these procedures between each other and assertain whether these techniques compare favourably to spinal anesthetic as a control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suprainguinal fascia iliaca compartment block (FICB)
Suprainguinal fascia iliaca compartment block (FICB) is a technique that involves injection of local anesthetics underneath the fascia of the iliacus muscle to block the femoral nerve, the lateral femoral cutaneous nerve and, possibly, the obturator nerve.
Bupivacaine Hydrochloride 0.25% Injection Solution_#2
40cc
EPINEPHrine 1:200,000 / Prilocaine HCl 4 % 1.8 ML Cartridge
10cc
Ketorolac
15mg
Pericapsular nerve group block (PENG)
The pericapsular nerve group block (PENG) is a technique that involves injection of local anesthetic in the musculofascial plane between the psoas muscle and the superior pubic ramus.
EPINEPHrine 1:200,000 / Prilocaine HCl 4 % 1.8 ML Cartridge
10cc
Bupivacaine Hydrochloride 0.5% Injection Solution_#2
20cc
Ketorolac
15mg
Local analgesia infiltration (LAI)
local anesthetic infiltration (LAI) into the anterior pericapsular tissues
Bupivacaine Hydrochloride 0.25% Injection Solution_#2
40cc
EPINEPHrine 1:200,000 / Prilocaine HCl 4 % 1.8 ML Cartridge
10cc
Ketorolac
15mg
No adjunct: spinal anaesthesia (control)
Standard spinal anesthesia technique
Bupivacaine Hydrochloride 0.5% Injection Solution_#2
20cc
Ketorolac
15mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine Hydrochloride 0.25% Injection Solution_#2
40cc
EPINEPHrine 1:200,000 / Prilocaine HCl 4 % 1.8 ML Cartridge
10cc
Bupivacaine Hydrochloride 0.5% Injection Solution_#2
20cc
Ketorolac
15mg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written consent
* Any gender
Exclusion Criteria
* Anesthesia other than spinal (general, epidural, other)
* Body mass index (BMI) \> 45 kg/m2
* Allergies to study medication
* Previous fracture to affected area
* Previous surgery to the affected hip
* Diagnosis other than osteoarthritis (avascular necrosis, significant deformity such as post-Perthes, slipped capital femoral epiphysis, dysplasia classified as Crowe 3 or 4, or other diagnoses causing significant deformity of the femoral head or acetabulum)
* THA for hip fractures
* Patients taking daily opiod analgesics pre-operatively
* Anesthetist on day of surgery who does not perform FICB and PENG and no alternate anesthetist available to perform the block
* Patients who do not understand, read or communicate in either French or English
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Mary's Research Center, Canada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anthony Albers, MD
MD, Orthopaedic Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Anthony Albers, MDCM, FRCSC
Role: PRINCIPAL_INVESTIGATOR
McGill University, Department of Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Mary's Hospital Center
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMHC - 21- 02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.